Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies
• Hepatitis B virus is highly prevalent and may increase the risk of developing NHL. • A meta-analysis was used to identify if HBV may increase risk of HL or MM. • Our results suggest HBV seropositivity may increase the risk of developing HL. • Our results suggest HBV seropositivity may increase the...
Ausführliche Beschreibung
Autor*in: |
Dalia, Samir [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2015 |
---|
Schlagwörter: |
---|
Umfang: |
9 |
---|
Übergeordnetes Werk: |
Enthalten in: N - Li, Danyang ELSEVIER, 2019, clinical and laboratory studies, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:39 ; year:2015 ; number:12 ; pages:1325-1333 ; extent:9 |
Links: |
---|
DOI / URN: |
10.1016/j.leukres.2015.09.008 |
---|
Katalog-ID: |
ELV02326411X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV02326411X | ||
003 | DE-627 | ||
005 | 20230623170005.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2015 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.leukres.2015.09.008 |2 doi | |
028 | 5 | 2 | |a GBVA2015003000011.pica |
035 | |a (DE-627)ELV02326411X | ||
035 | |a (ELSEVIER)S0145-2126(15)30378-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 333.7 |a 610 |q VZ |
084 | |a 43.12 |2 bkl | ||
084 | |a 43.13 |2 bkl | ||
084 | |a 44.13 |2 bkl | ||
100 | 1 | |a Dalia, Samir |e verfasserin |4 aut | |
245 | 1 | 0 | |a Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies |
264 | 1 | |c 2015 | |
300 | |a 9 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a • Hepatitis B virus is highly prevalent and may increase the risk of developing NHL. • A meta-analysis was used to identify if HBV may increase risk of HL or MM. • Our results suggest HBV seropositivity may increase the risk of developing HL. • Our results suggest HBV seropositivity may increase the risk of developing MM. | ||
650 | 7 | |a Hodgkin Lymphoma |2 Elsevier | |
650 | 7 | |a Multiple myeloma |2 Elsevier | |
650 | 7 | |a Hepatitis B |2 Elsevier | |
650 | 7 | |a Meta-analysis |2 Elsevier | |
700 | 1 | |a Dunker, Kelli |4 oth | |
700 | 1 | |a Sokol, Lubomir |4 oth | |
700 | 1 | |a Mhaskar, Rahul |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Li, Danyang ELSEVIER |t N |d 2019 |d clinical and laboratory studies |g Amsterdam [u.a.] |w (DE-627)ELV002185202 |
773 | 1 | 8 | |g volume:39 |g year:2015 |g number:12 |g pages:1325-1333 |g extent:9 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.leukres.2015.09.008 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-GGO | ||
936 | b | k | |a 43.12 |j Umweltchemie |q VZ |
936 | b | k | |a 43.13 |j Umwelttoxikologie |q VZ |
936 | b | k | |a 44.13 |j Medizinische Ökologie |q VZ |
951 | |a AR | ||
952 | |d 39 |j 2015 |e 12 |h 1325-1333 |g 9 | ||
953 | |2 045F |a 610 |
author_variant |
s d sd |
---|---|
matchkey_str |
daliasamirdunkerkellisokollubomirmhaskar:2015----:eaiibeooiiiynrsodvlpnmlilmeoarogilmhmaea |
hierarchy_sort_str |
2015 |
bklnumber |
43.12 43.13 44.13 |
publishDate |
2015 |
allfields |
10.1016/j.leukres.2015.09.008 doi GBVA2015003000011.pica (DE-627)ELV02326411X (ELSEVIER)S0145-2126(15)30378-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Dalia, Samir verfasserin aut Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Hepatitis B virus is highly prevalent and may increase the risk of developing NHL. • A meta-analysis was used to identify if HBV may increase risk of HL or MM. • Our results suggest HBV seropositivity may increase the risk of developing HL. • Our results suggest HBV seropositivity may increase the risk of developing MM. Hodgkin Lymphoma Elsevier Multiple myeloma Elsevier Hepatitis B Elsevier Meta-analysis Elsevier Dunker, Kelli oth Sokol, Lubomir oth Mhaskar, Rahul oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:39 year:2015 number:12 pages:1325-1333 extent:9 https://doi.org/10.1016/j.leukres.2015.09.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 39 2015 12 1325-1333 9 045F 610 |
spelling |
10.1016/j.leukres.2015.09.008 doi GBVA2015003000011.pica (DE-627)ELV02326411X (ELSEVIER)S0145-2126(15)30378-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Dalia, Samir verfasserin aut Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Hepatitis B virus is highly prevalent and may increase the risk of developing NHL. • A meta-analysis was used to identify if HBV may increase risk of HL or MM. • Our results suggest HBV seropositivity may increase the risk of developing HL. • Our results suggest HBV seropositivity may increase the risk of developing MM. Hodgkin Lymphoma Elsevier Multiple myeloma Elsevier Hepatitis B Elsevier Meta-analysis Elsevier Dunker, Kelli oth Sokol, Lubomir oth Mhaskar, Rahul oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:39 year:2015 number:12 pages:1325-1333 extent:9 https://doi.org/10.1016/j.leukres.2015.09.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 39 2015 12 1325-1333 9 045F 610 |
allfields_unstemmed |
10.1016/j.leukres.2015.09.008 doi GBVA2015003000011.pica (DE-627)ELV02326411X (ELSEVIER)S0145-2126(15)30378-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Dalia, Samir verfasserin aut Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Hepatitis B virus is highly prevalent and may increase the risk of developing NHL. • A meta-analysis was used to identify if HBV may increase risk of HL or MM. • Our results suggest HBV seropositivity may increase the risk of developing HL. • Our results suggest HBV seropositivity may increase the risk of developing MM. Hodgkin Lymphoma Elsevier Multiple myeloma Elsevier Hepatitis B Elsevier Meta-analysis Elsevier Dunker, Kelli oth Sokol, Lubomir oth Mhaskar, Rahul oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:39 year:2015 number:12 pages:1325-1333 extent:9 https://doi.org/10.1016/j.leukres.2015.09.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 39 2015 12 1325-1333 9 045F 610 |
allfieldsGer |
10.1016/j.leukres.2015.09.008 doi GBVA2015003000011.pica (DE-627)ELV02326411X (ELSEVIER)S0145-2126(15)30378-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Dalia, Samir verfasserin aut Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Hepatitis B virus is highly prevalent and may increase the risk of developing NHL. • A meta-analysis was used to identify if HBV may increase risk of HL or MM. • Our results suggest HBV seropositivity may increase the risk of developing HL. • Our results suggest HBV seropositivity may increase the risk of developing MM. Hodgkin Lymphoma Elsevier Multiple myeloma Elsevier Hepatitis B Elsevier Meta-analysis Elsevier Dunker, Kelli oth Sokol, Lubomir oth Mhaskar, Rahul oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:39 year:2015 number:12 pages:1325-1333 extent:9 https://doi.org/10.1016/j.leukres.2015.09.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 39 2015 12 1325-1333 9 045F 610 |
allfieldsSound |
10.1016/j.leukres.2015.09.008 doi GBVA2015003000011.pica (DE-627)ELV02326411X (ELSEVIER)S0145-2126(15)30378-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Dalia, Samir verfasserin aut Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies 2015 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Hepatitis B virus is highly prevalent and may increase the risk of developing NHL. • A meta-analysis was used to identify if HBV may increase risk of HL or MM. • Our results suggest HBV seropositivity may increase the risk of developing HL. • Our results suggest HBV seropositivity may increase the risk of developing MM. Hodgkin Lymphoma Elsevier Multiple myeloma Elsevier Hepatitis B Elsevier Meta-analysis Elsevier Dunker, Kelli oth Sokol, Lubomir oth Mhaskar, Rahul oth Enthalten in Elsevier Science Li, Danyang ELSEVIER N 2019 clinical and laboratory studies Amsterdam [u.a.] (DE-627)ELV002185202 volume:39 year:2015 number:12 pages:1325-1333 extent:9 https://doi.org/10.1016/j.leukres.2015.09.008 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO 43.12 Umweltchemie VZ 43.13 Umwelttoxikologie VZ 44.13 Medizinische Ökologie VZ AR 39 2015 12 1325-1333 9 045F 610 |
language |
English |
source |
Enthalten in N Amsterdam [u.a.] volume:39 year:2015 number:12 pages:1325-1333 extent:9 |
sourceStr |
Enthalten in N Amsterdam [u.a.] volume:39 year:2015 number:12 pages:1325-1333 extent:9 |
format_phy_str_mv |
Article |
bklname |
Umweltchemie Umwelttoxikologie Medizinische Ökologie |
institution |
findex.gbv.de |
topic_facet |
Hodgkin Lymphoma Multiple myeloma Hepatitis B Meta-analysis |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
N |
authorswithroles_txt_mv |
Dalia, Samir @@aut@@ Dunker, Kelli @@oth@@ Sokol, Lubomir @@oth@@ Mhaskar, Rahul @@oth@@ |
publishDateDaySort_date |
2015-01-01T00:00:00Z |
hierarchy_top_id |
ELV002185202 |
dewey-sort |
3610 |
id |
ELV02326411X |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV02326411X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623170005.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.leukres.2015.09.008</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015003000011.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV02326411X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0145-2126(15)30378-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">333.7</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Dalia, Samir</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Hepatitis B virus is highly prevalent and may increase the risk of developing NHL. • A meta-analysis was used to identify if HBV may increase risk of HL or MM. • Our results suggest HBV seropositivity may increase the risk of developing HL. • Our results suggest HBV seropositivity may increase the risk of developing MM.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hodgkin Lymphoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Multiple myeloma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis B</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Meta-analysis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dunker, Kelli</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sokol, Lubomir</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mhaskar, Rahul</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Li, Danyang ELSEVIER</subfield><subfield code="t">N</subfield><subfield code="d">2019</subfield><subfield code="d">clinical and laboratory studies</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002185202</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:1325-1333</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.leukres.2015.09.008</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">2015</subfield><subfield code="e">12</subfield><subfield code="h">1325-1333</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Dalia, Samir |
spellingShingle |
Dalia, Samir ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Hodgkin Lymphoma Elsevier Multiple myeloma Elsevier Hepatitis B Elsevier Meta-analysis Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies |
authorStr |
Dalia, Samir |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002185202 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 333 - Economics of land & energy |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies Hodgkin Lymphoma Elsevier Multiple myeloma Elsevier Hepatitis B Elsevier Meta-analysis Elsevier |
topic |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Hodgkin Lymphoma Elsevier Multiple myeloma Elsevier Hepatitis B Elsevier Meta-analysis |
topic_unstemmed |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Hodgkin Lymphoma Elsevier Multiple myeloma Elsevier Hepatitis B Elsevier Meta-analysis |
topic_browse |
ddc 610 ddc 333.7 bkl 43.12 bkl 43.13 bkl 44.13 Elsevier Hodgkin Lymphoma Elsevier Multiple myeloma Elsevier Hepatitis B Elsevier Meta-analysis |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
k d kd l s ls r m rm |
hierarchy_parent_title |
N |
hierarchy_parent_id |
ELV002185202 |
dewey-tens |
610 - Medicine & health 330 - Economics |
hierarchy_top_title |
N |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV002185202 |
title |
Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies |
ctrlnum |
(DE-627)ELV02326411X (ELSEVIER)S0145-2126(15)30378-7 |
title_full |
Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies |
author_sort |
Dalia, Samir |
journal |
N |
journalStr |
N |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology 300 - Social sciences |
recordtype |
marc |
publishDateSort |
2015 |
contenttype_str_mv |
zzz |
container_start_page |
1325 |
author_browse |
Dalia, Samir |
container_volume |
39 |
physical |
9 |
class |
610 610 DE-600 333.7 610 VZ 43.12 bkl 43.13 bkl 44.13 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Dalia, Samir |
doi_str_mv |
10.1016/j.leukres.2015.09.008 |
dewey-full |
610 333.7 |
title_sort |
hepatitis b seropositivity and risk of developing multiple myeloma or hodgkin lymphoma: a meta-analysis of observational studies |
title_auth |
Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies |
abstract |
• Hepatitis B virus is highly prevalent and may increase the risk of developing NHL. • A meta-analysis was used to identify if HBV may increase risk of HL or MM. • Our results suggest HBV seropositivity may increase the risk of developing HL. • Our results suggest HBV seropositivity may increase the risk of developing MM. |
abstractGer |
• Hepatitis B virus is highly prevalent and may increase the risk of developing NHL. • A meta-analysis was used to identify if HBV may increase risk of HL or MM. • Our results suggest HBV seropositivity may increase the risk of developing HL. • Our results suggest HBV seropositivity may increase the risk of developing MM. |
abstract_unstemmed |
• Hepatitis B virus is highly prevalent and may increase the risk of developing NHL. • A meta-analysis was used to identify if HBV may increase risk of HL or MM. • Our results suggest HBV seropositivity may increase the risk of developing HL. • Our results suggest HBV seropositivity may increase the risk of developing MM. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA SSG-OPC-GGO |
container_issue |
12 |
title_short |
Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies |
url |
https://doi.org/10.1016/j.leukres.2015.09.008 |
remote_bool |
true |
author2 |
Dunker, Kelli Sokol, Lubomir Mhaskar, Rahul |
author2Str |
Dunker, Kelli Sokol, Lubomir Mhaskar, Rahul |
ppnlink |
ELV002185202 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth |
doi_str |
10.1016/j.leukres.2015.09.008 |
up_date |
2024-07-06T18:26:17.393Z |
_version_ |
1803855202767339520 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV02326411X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623170005.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.leukres.2015.09.008</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015003000011.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV02326411X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0145-2126(15)30378-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">333.7</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.12</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Dalia, Samir</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Hepatitis B seropositivity and risk of developing multiple myeloma or Hodgkin lymphoma: A meta-analysis of observational studies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Hepatitis B virus is highly prevalent and may increase the risk of developing NHL. • A meta-analysis was used to identify if HBV may increase risk of HL or MM. • Our results suggest HBV seropositivity may increase the risk of developing HL. • Our results suggest HBV seropositivity may increase the risk of developing MM.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hodgkin Lymphoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Multiple myeloma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis B</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Meta-analysis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dunker, Kelli</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sokol, Lubomir</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mhaskar, Rahul</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Li, Danyang ELSEVIER</subfield><subfield code="t">N</subfield><subfield code="d">2019</subfield><subfield code="d">clinical and laboratory studies</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV002185202</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:39</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:1325-1333</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.leukres.2015.09.008</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.12</subfield><subfield code="j">Umweltchemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">39</subfield><subfield code="j">2015</subfield><subfield code="e">12</subfield><subfield code="h">1325-1333</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.401063 |